|
|
|
Insider
Information: |
Black Bear Offshore Master Fund Lp |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
48,695,742 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,619,728,390 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
48,695,742 |
|
|
Total
Value |
$1,619,728,390 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neose Technologies Inc |
NTEC |
10% Owner |
2005-02-18 |
3,049,996 |
|
0 |
Premium* |
|
Seachange International Inc |
SEAC |
10% Owner |
2005-04-12 |
2,091,253 |
|
0 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-07-01 |
4,186,238 |
2005-11-03 |
0 |
Premium* |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
7,971,542 |
2006-02-24 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2008-08-27 |
12,116,463 |
2008-04-03 |
0 |
Premium* |
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-07-01 |
9,366,039 |
2009-03-12 |
0 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2009-05-31 |
9,914,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
258 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,661,297 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-03-28 |
4 |
B |
$28.10 |
$3,342,017 |
D/D |
118,933 |
13,780,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-03 |
4 |
B |
$30.50 |
$4,738,918 |
D/D |
155,000 |
13,935,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-07 |
4 |
B |
$31.52 |
$1,576,000 |
D/D |
50,000 |
13,985,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-08 |
4 |
B |
$30.96 |
$1,548,000 |
D/D |
50,000 |
14,035,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-09 |
4 |
B |
$30.05 |
$6,271,435 |
D/D |
208,700 |
14,243,930 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-11 |
4 |
B |
$29.80 |
$8,723,362 |
D/D |
291,300 |
14,535,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-14 |
4 |
B |
$29.37 |
$4,336,235 |
D/D |
147,308 |
14,682,538 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-15 |
4 |
B |
$29.24 |
$840,510 |
D/D |
28,689 |
14,711,227 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-16 |
4 |
B |
$30.78 |
$599,317 |
D/D |
19,471 |
14,730,698 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-17 |
4 |
B |
$30.35 |
$1,517,500 |
D/D |
50,000 |
14,780,698 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-21 |
4 |
B |
$28.52 |
$25,521,703 |
D/D |
894,000 |
15,674,698 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
16,031,350 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-05-07 |
4 |
B |
$27.88 |
$4,649,747 |
D/D |
166,619 |
16,197,969 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-06-06 |
4 |
B |
$29.91 |
$3,328,055 |
D/D |
111,207 |
16,309,176 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-08-27 |
4 |
S |
$20.07 |
$89,149,814 |
D/D |
(4,192,713) |
12,116,463 |
0 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,748,910 |
|
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-11-03 |
4 |
B |
$5.78 |
$50,032 |
D/D |
8,656 |
4,757,566 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-11-04 |
4 |
B |
$6.02 |
$179,450 |
D/D |
29,800 |
4,787,366 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-11-08 |
4 |
B |
$6.13 |
$79,077 |
D/D |
12,900 |
4,800,266 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-11-09 |
4 |
B |
$6.13 |
$27,033 |
D/D |
4,410 |
4,804,676 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2005-11-15 |
4/A |
B |
$0.00 |
$0 |
D/D |
0 |
5,805,932 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
officerTitle |
|
2005-12-15 |
4 |
B |
$6.78 |
$202,586 |
D/D |
29,880 |
4,834,556 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
officerTitle |
|
2005-12-16 |
4 |
B |
$6.78 |
$27,120 |
D/D |
4,000 |
4,838,556 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
officerTitle |
|
2005-12-19 |
4 |
B |
$6.79 |
$184,769 |
D/D |
27,212 |
4,865,768 |
2.45 |
- |
|
258 Records found
|
|
Page 1 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|